AC Immune SA
ACIU
$2.20
$0.052.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.35% | -17.67% | -382.73% | 125.28% | -23.20% |
| Total Depreciation and Amortization | 10.93% | 13.01% | -1.50% | 0.92% | -4.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.59% | 260.03% | 2.02% | -113.25% | 3,974.73% |
| Change in Net Operating Assets | 218.00% | -110.03% | 215.84% | -123.10% | 359.38% |
| Cash from Operations | 9.66% | -409.75% | 141.32% | -120.25% | 6,795.22% |
| Capital Expenditure | -12.29% | -292.88% | 47.54% | -159.84% | 73.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 679.30% | 188.64% | -91.85% | 97.35% | -214.17% |
| Cash from Investing | 759.57% | 177.31% | -80.56% | 97.12% | -211.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.79% | -47.95% | 0.58% | 0.58% | -3.59% |
| Issuance of Common Stock | -- | -- | -- | -- | 6,650.00% |
| Repurchase of Common Stock | -- | -- | -2,400.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -400.00% | -- | 100.00% | 95.41% |
| Cash from Financing | -4.32% | -27.95% | -12.15% | -191.55% | 91.28% |
| Foreign Exchange rate Adjustments | -822.16% | -113.50% | 169.88% | -10.59% | -244.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.49% | -513.10% | 119.85% | -267.64% | 75.50% |